Controlled targeting of liposomal doxorubicin via the folate receptor in vitro

Journal of Controlled Release

Volumn 92, Issue 1-2, 2003, Pages 49-67

  Saul, Justin M ^a   Annapragada, Ananth ^b   Natarajan, Jayaganesh V ^b   Bellamkonda, Ravi V ^a,c  

^a Case Western Reserve University   (United States)

^b Cleveland State University   (United States)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Brain tumor; Drug delivery; Glioma; Insertion; Ligand

Indexed keywords

CELLS; OPTIMIZATION; ORGANIC ACIDS; TUMORS;

DOXORUBICIN;

DRUG PRODUCTS;

1,2 DIPALMITOYLGLYCEROPHOSPHOETHANOLAMINE MACROGOL 2000; DOXORUBICIN; FOLATE RECEPTOR; LIPOSOME; MACROGOL DERIVATIVE; UNCLASSIFIED DRUG; VITAMIN RECEPTOR;

ANIMAL CELL; ARTICLE; BRAIN CELL; CELL KILLING; CELL PROLIFERATION; COCULTURE; CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG UPTAKE; GLIOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0141518623     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(03)00295-5     Document Type: Article

References (28)

1. Lee R.J., Low P.S. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim. Biophys. Acta. 1233:1995;134-144.
2. Lee R.J., Low P.S. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem. 269:1994;3198-3204.
3. Gabizon A., et al. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Bioconjug. Chem. 10:1999;289-298.
4. Anderson K.E., Eliot L.A., Stevenson B.R., Rogers J.A. Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form. Pharm. Res. 18:2001;316-322.
5. Lee R.J., Huang L. Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J. Biol. Chem. 271:1996;8481-8487.
6. Wang S., Lee R.J., Cauchon G., Gorenstein D.G., Low P.S. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol. Proc. Natl. Acad. Sci. USA. 92:1995;3318-3322.
7. Mathias C.J., et al. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate. J. Nucl. Med. 37:1996;1003-1008.
8. Wong J.Y., Kuhl T.L., Israelachvili J.N., Mullah N., Zalipsky S. Direct measurement of a tethered ligand-receptor interaction potential. Science. 275:1997;820-822.
9. Weitman S.D., et al. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 52:1992;3396-3401.
10. Maruyama K., et al. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies. Biochim. Biophys. Acta. 1234:1995;74-80.
11. Uster P.S., et al. Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time. FEBS Lett. 386:1996;243-246.
12. Ishida T., Iden D.L., Allen T.M. A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs. FEBS Lett. 460:1999;129-133.
13. Iden D.L., Allen T.M. In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach. Biochim. Biophys. Acta. 1513:2001;207-216.
14. Moreira J.N., Ishida T., Gaspar R., Allen T.M. Use of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity. Pharm. Res. 19:2002;265-269.
15. Shen F., Wang H., Zheng X., Ratnam M. Expression levels of functional folate receptors alpha and beta are related to the number of N-glycosylated sites. Biochem. J. 327:1997;759-764.
16. Corona G., Giannini F., Fabris M., Toffoli G., Boiocchi M. Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells. Int. J. Cancer. 75:1998;125-133.
17. Lasic D. Lasic D. Liposomes: From Physics to Applications. 1993;63-107 Elsevier, New York.
18. Bolotin E.M., et al. Ammonium sulfate gradients for efficient and stable remote loading of amphipathic weak bases into liposomes and ligandoliposomes. J. Liposome Res. 4:1994;455-479.
19. Reif V.D., Reamer J.T., Grady L.T. Chromatographic assays for folic acid. J. Pharm. Sci. 66:1977;1112-1116.
20. Mayer L.D., Bally M.B., Hope M.J., Cullis P.R. Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential. Biochim. Biophys. Acta. 816:1985;294-302.
21. Eavarone D.A., Yu X., Bellamkonda R.V. Targeted drug delivery to C6 glioma by transferrin-coupled liposomes. J. Biomed. Mater. Res. 51:2000;10-14.
22. Recht L., Torres C.O., Smith T.W., Raso V., Griffin T.W. Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy [see comments]. J. Neurosurg. 72:1990;941-945.
23. Bredel M., Pollack I.F., Hamilton R.L., James C.D. Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood. Clin. Cancer Res. 5:1999;1786-1792.
24. Blume G., et al. Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. Biochim. Biophys. Acta. 1149:1993;180-184.
25. Barth R.F. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J. Neurooncol. 36:1998;91-102.
26. Altinoz M.A., et al. Vascularization pattern of C6 glioma is modified with medroxyprogesterone acetate and ibuprofen in Wistar rat brain. Pathol. Oncol. Res. 7:2001;185-189.
27. Leamon C.P., Low P.S. Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc. Natl. Acad. Sci. USA. 88:1991;5572-5576.
28. Koukourakis M.I., et al. High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours. Br. J. Cancer. 83:2000;1281-1286.